The main components of PML bodies in human cells are the six nuclear isoforms of the protein of promyelocytic leukemia (PML) formed via alternative splicing, therefore, they differ in size and amino acid sequence of their C-terminal domains [78,79,80]. This evidence concerns the gene PML and leukemia.